Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease
Condition: Idiopathic Parkinson's Disease Intervention: Biological: Aadipose-Derived Mesenchymal Stem Cells Sponsor: Taiwan Mitochondrion Applied Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials